NASDAQ:RXRX Recursion Pharmaceuticals (RXRX) Earnings Date, Estimates & Call Transcripts $8.63 +0.20 (+2.37%) (As of 06/6/2023 ET) Add Compare Share Share Today's Range$8.18▼$8.7050-Day Range$4.56▼$9.2552-Week Range$4.54▼$14.18Volume1.27 million shsAverage Volume1.46 million shsMarket Capitalization$1.66 billionP/E RatioN/ADividend YieldN/APrice Target$12.40 EarningsProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Earnings Summary Upcoming Earnings DateAug. 8EstimatedActual EPS (May. 8) -$0.34 Beat By $0.01 Consensus EPS (May. 8) -$0.35 Last Year's Q2 EPS (5/10/2022) -$0.33Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRXRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RXRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.Recursion Pharmaceuticals Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20232($0.34)($0.33)($0.34)Q2 20232($0.38)($0.36)($0.37)Q3 20234($0.35)($0.34)($0.35)Q4 20232($0.34)($0.17)($0.26)FY 202310($1.41)($1.20)($1.31)Q1 20241($0.33)($0.33)($0.33)Q2 20241($0.33)($0.33)($0.33)Q3 20241($0.35)($0.35)($0.35)Q4 20241($0.83)($0.83)($0.83)FY 20244($1.84)($1.84)($1.84) Get Recursion Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for RXRX and its competitors with MarketBeat's FREE daily newsletter. RXRX Earnings Date and InformationRecursion Pharmaceuticals last issued its quarterly earnings data on May 8th, 2023. The reported ($0.34) EPS for the quarter, topping the consensus estimate of ($0.35) by $0.01. The business had revenue of $12.13 million for the quarter, compared to analyst estimates of $15.93 million. Recursion Pharmaceuticals has generated ($1.38) earnings per share over the last year (($1.38) diluted earnings per share). Earnings for Recursion Pharmaceuticals are expected to decrease in the coming year, from ($1.41) to ($1.62) per share. Recursion Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off prior year's report dates.Read More Recursion Pharmaceuticals Earnings History by Quarter Export to ExcelDateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2023(Estimated) 5/8/20233/31/2023($0.35)($0.34)+$0.01($0.34)$15.93 million$12.13 million2/27/2023Q4 2022($0.15)($0.31)($0.16)($0.31)$66.68 million$13.68 million11/8/2022Q3 2022($0.36)($0.35)+$0.01($0.35)$6.43 million$13.16 million8/9/2022Q2 2022($0.35)($0.38)($0.03)($0.38)$5.60 million$7.67 million5/10/2022Q1 2022$0.51($0.33)($0.84)($0.33)$152.90 million$5.33 million3/23/2022Q4 2021($0.30)($0.38)($0.08)($0.38)$7.62 million$2.53 million11/10/20219/30/2021($0.28)($0.28)($0.28)$2.62 million$2.53 million8/12/20216/30/2021($0.23)($0.31)($0.08)($0.31)$2.65 million$2.55 million5/12/20213/31/2021($0.24)($1.33)($1.09)($1.33)$2.56 millionRecursion Pharmaceuticals Earnings - Frequently Asked Questions When is Recursion Pharmaceuticals's earnings date? Recursion Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off last year's report dates. Learn more on RXRX's earnings history. Did Recursion Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Recursion Pharmaceuticals (NASDAQ:RXRX) reported ($0.34) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.35) by $0.01. Learn more on analysts' earnings estimate vs. RXRX's actual earnings. How much revenue does Recursion Pharmaceuticals generate each year? Recursion Pharmaceuticals (NASDAQ:RXRX) has a recorded annual revenue of $39.84 million. How much profit does Recursion Pharmaceuticals generate each year? Recursion Pharmaceuticals (NASDAQ:RXRX) has a recorded net income of -$239.48 million. RXRX has generated -$1.38 earnings per share over the last four quarters. What is Recursion Pharmaceuticals's EPS forecast for next year? Recursion Pharmaceuticals's earnings are expected to decrease from ($1.41) per share to ($1.62) per share in the next year. More Earnings Resources from MarketBeat Related Companies: SWTX Earnings Date VCEL Earnings Date BCRX Earnings Date IOVA Earnings Date IBRX Earnings Date RLAY Earnings Date KYMR Earnings Date REPL Earnings Date ACLX Earnings Date SANA Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Trading Channel Breakout in Lululemon Brought by EarningsNordstrom's Earnings Beat, A Rally In The MakingMacy's Stock Earnings, A Pivotal StoryC3.AI's Lukewarm Earnings: Failing to Cash in on AI Boom?NetApp Is Gearing Up To Breakout After Earnings Top EstimatesWhat U-Haul Earnings Are Showing, Heading Up?Can Earnings Narrow The Value Gap In Hewlett Packard? This page (NASDAQ:RXRX) was last updated on 6/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recursion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.